Insight Molecular Diagnostics (IMDX) Net Income towards Common Stockholders Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) Net Income towards Common Stockholders Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -159.32% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 9.95% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 7.86% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 14.74% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -27.15% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 57.67% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -44.49% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 2.29% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 3.59% |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | 33.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.85% |
| Dec 31, 2025 | 31.50% |
| Sep 30, 2025 | 19.56% |
| Jun 30, 2025 | -112.38% |
| Mar 31, 2025 | 28.54% |
| Dec 31, 2024 | -152.55% |
| Sep 30, 2024 | -101.78% |
| Jun 30, 2024 | 46.93% |
| Mar 31, 2024 | -389,545.14% |
| Dec 31, 2023 | -246.04% |
| Sep 30, 2023 | 30.54% |
| Jun 30, 2023 | -3.25% |
| Mar 31, 2023 | 100.02% |
| Dec 31, 2022 | 125.32% |
| Sep 30, 2022 | 30.24% |
| Jun 30, 2022 | 20.21% |
| Mar 31, 2022 | -162.59% |
| Dec 31, 2021 | -441.50% |
| Sep 30, 2021 | -103.45% |
| Jun 30, 2021 | -51.68% |